Glu Mobile Inc. (NASDAQ:GLUU) notched a 1.22% intraday gain moving at $2.49. When the opening bell rang, the price was $2.46. The number of shares that were traded during the day was 2.1 million, which corresponds to its 3-month volume average of 5.14 million shares a day.

Glu Mobile Inc. (GLUU) Analyst Opinion

Glu Mobile Inc. has a consensus outperform rating from 7 Wall Street analysts, and the number of shares currently sold short amount to at least 13.2% of shares outstanding. The stock sank -5.32% last month and is up 28.35 this year. Wall Street is only getting more bullish on the stock, with 3 of analysts who cover GLUU having a buy-equivalent rating. Analysts have placed a $2.87 price target on Glu Mobile Inc., suggesting a 15.26% gain from recent close. It’s currently trading about -15.59% below its 52-week high.

Glu Mobile Inc. Earnings Surprise

Glu Mobile Inc. (GLUU) surprised the stock market in its last reported earnings when it earned -$0.01 a piece versus the consensus-estimated -$0.07. Its revenue totaled $53.52 million up 15.57% from the previous quarter.

Glu Mobile Inc. (NASDAQ:GLUU) Intraday View

This stock (GLUU) is ahead of its 52-week low with 43.93%. Its last month’s stock price volatility remained 3.32% which for the week stands at 3.65%. The share price has moved backward from its 20 days moving average, trading at a distance of -2.18% and stays -2.93% away from its 50 days moving average. Over the last five days, shares have faced -0.4% losses and now is up 10.44% since hitting its 200-day moving average of $2.3. Glu Mobile Inc. (GLUU) has made its way to a 12-month gain of 5.96%.

Turning to Novavax, Inc. (NASDAQ:NVAX), its shares were trading at $1.16 a retreat of $-0.02, on the trading floor. The stock, after opening at $1.18, touched a high of $1.22 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2.7. Novavax, Inc. has 1 buy ratings, 6 holds and 0 sells even after the stock tumbled -86.34% from its high of $8.49 to a $330.6 million market value through last close.

Novavax, Inc. (NVAX) Consensus Price Target

The company’s consensus rating on Reuter’s scale remained unchanged from 2.71 to 2.71 during a month. Analysts set a 12-month price target of $3.48 a share. The target implies a 200% spike from where the shares are currently trading. Also, the current price highlights a discount of 934.48% to analysts’ high consensus price target.

Novavax, Inc. (NASDAQ:NVAX) Intraday Trading

The counter witnessed a trading volume of 5.35 million shares versus an average volume of 5.73 million shares during last trading session. Its last month’s stock price volatility remained 4.9% which for the week approaches 5.23%. The lowest price the stock reached in the last trading day was $1.14 and compares with the $0.73 52-week low. The stock recovered 58.9% since its low point and has performed -7.94% year-to-date.

Previous articleAnalyst Commentary On Huntsman Corporation (HUN), The Procter & Gamble Company (PG)
Next articleAn End-of-Day Technical Review: Kitov Pharmaceuticals Holdings Ltd. (KTOV), ArcelorMittal (MT)